InvestorsHub Logo
Followers 43
Posts 3009
Boards Moderated 0
Alias Born 09/23/2013

Re: None

Tuesday, 09/02/2014 9:31:26 PM

Tuesday, September 02, 2014 9:31:26 PM

Post# of 130502
$AMBS announces huge LymPro revenue guidance: $150 million/year as an RUO - research use only device. Then post CLIA, formal commercialization = $500-Mil. - $1-Bil. market!